SNPHF (Santen Pharmaceutical Co) Dividend Payout Ratio: 0.40 (As of Mar. 2026) — 13% Below Median


SNPHF Santen Pharmaceutical Co Ltd SNPHF
81 GF Score
Price $13.05
GF Value $10.30
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Santen Pharmaceutical Co Dividend Payout Ratio?

Santen Pharmaceutical Co SNPHF +4.40% 81 Dividend Payout Ratio is 0.40 as of Mar. 2026, which is 13% below its 10-year median of 0.46. GuruFocus rates SNPHF with a GF Score™ of 81/100 and a GF Value™ of $10.30 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 444 Drug Manufacturers companies, Santen Pharmaceutical Co ranks better than 58.11% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Santen Pharmaceutical Co's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.40.

The historical rank and industry rank for Santen Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:

SNPHF' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.3   Med: 0.46   Max: 1.2
Current: 0.33

During the past 13 years, the highest Dividend Payout Ratio of Santen Pharmaceutical Co was 1.20. The lowest was 0.30. And the median was 0.46.

SNPHF's Dividend Payout Ratio is ranked better than
58.11% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.375 vs SNPHF: 0.33

As of today (2026-06-29), the Dividend Yield % of Santen Pharmaceutical Co is 1.83%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Santen Pharmaceutical Co was 3.33%. The lowest was 1.21%. And the median was 1.85%.

Santen Pharmaceutical Co's Dividends per Share for the months ended in Mar. 2026 was $0.12.

During the past 12 months, Santen Pharmaceutical Co's average Dividends Per Share Growth Rate was 5.60% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 5.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 5.60% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 4.40% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Santen Pharmaceutical Co was 17.00% per year. The lowest was 1.30% per year. And the median was 5.80% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Santen Pharmaceutical Co (OTCPK:SNPHF) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Santen Pharmaceutical Co Dividend Payout Ratio Related Terms

Santen Pharmaceutical Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Santen Pharmaceutical Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co Dividend Payout Ratio Chart

Santen Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.00 0.46 0.35 0.33

Santen Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 0.00 0.78 0.00 0.40

SNPHF vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Santen Pharmaceutical Co Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Dividend Payout Ratio falls into.


SNPHF
81GF Score
Santen Pharmaceutical Co Ltd SNPHF
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Santen Pharmaceutical Co Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Santen Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2026 )/ EPS without NRI (A: Mar. 2026 )
=0.239/ 0.717
=0.33

Santen Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0.12/ 0.301
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.40 mean?
Santen Pharmaceutical Co (SNPHF) has a Dividend Payout Ratio of 0.40 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Santen Pharmaceutical Co and its competitors. This is 13% below median its historical median of 0.46. Over the past decade, Santen Pharmaceutical Co's Dividend Payout Ratio has ranged from 0.30 to 1.20. According to the industry distribution chart, Santen Pharmaceutical Co ranks #186 out of 444 companies in the Drug Manufacturers industry, placing it in the top 41.9%.
Is Santen Pharmaceutical Co's Dividend Payout Ratio too high?
Santen Pharmaceutical Co's current Dividend Payout Ratio of 0.40 is 13% below median its 10-year median of 0.46. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 1.20. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Santen Pharmaceutical Co's value of 0.40 is 6.7% above this industry median. Based on the distribution chart, Santen Pharmaceutical Co ranks #186 out of 444 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Santen Pharmaceutical Co has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Santen Pharmaceutical Co's Dividend Payout Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Santen Pharmaceutical Co ranks #186 out of 444 companies for Dividend Payout Ratio. This puts Santen Pharmaceutical Co in the upper half of its industry. The industry median Dividend Payout Ratio is 0.38. Santen Pharmaceutical Co's value of 0.40 is 6.7% above this benchmark. Historically, Santen Pharmaceutical Co's own Dividend Payout Ratio has ranged from 0.30 to 1.20 over the past decade. While the company's 10-year median is 0.46 vs. the industry median of 0.38, Santen Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Santen Pharmaceutical Co's current Dividend Payout Ratio of 0.40 is 6.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Santen Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Santen Pharmaceutical Co's current Dividend Payout Ratio is 0.40, which is 13% below median its own 10-year median of 0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Santen Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Santen Pharmaceutical Co (SNPHF) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.30, compared to a current price of $13.05 — trading 26.7% above its estimated fair value. The current Dividend Payout Ratio is 0.40, which is 13% below median its 10-year median of 0.46 and 6.7% above the Drug Manufacturers industry median of 0.38. Santen Pharmaceutical Co's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Santen Pharmaceutical Co (SNPHF), the current Dividend Payout Ratio is 0.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Santen Pharmaceutical Co (SNPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Santen Pharmaceutical Co stock appears to be overvalued. The current stock price of $13.05 is trading 26.7% above its estimated GF Value™ of $10.30. GuruFocus considers Santen Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for SNPHF:

  • Dividend Payout Ratio: 0.40 (13% below median its 10-year median of 0.46)
  • GF Value™: $10.30 vs. price of $13.05 (26.7% above fair value)
  • GF Score™: 81/100 with 6 warning signs
  • Industry Position: 6.7% above the Drug Manufacturers median (#186 of 444)

No single metric tells the full story. See the SNPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Santen Pharmaceutical Co Business Description

Other Exchanges SNPHY:USA4536:Japan
Address 4-20 Ofukacho, Grand Front Osaka Tower A, Kita-ku, Osaka Prefecture, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
81GF Score

Get the complete analysis for SNPHF

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.05
Price
$10.30
GF Value